Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases. Founded by David Eveleth, Kenneth Thomas, Michael Blaber, and Ralph Bradshaw in 2014, Trefoil Therapeutics is backed by National Institutes of Health, Hatteras Venture Partners, Correlation Ventures, Solasta Ventures, and Bios Partners and is headquartered in San Diego.
FOUNDED:
2014
INDUSTRY:
Biotechnology, Health Care, Therapeutics
FOUNDERS:
David Eveleth, Kenneth Thomas, Michael Blaber, Ralph Bradshaw
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
